These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 32745151)
1. Cardiovascular risk in persons at risk of developing rheumatoid arthritis. van Boheemen L; van Beers-Tas MH; Kroese JM; van de Stadt LA; van Schaardenburg D; Nurmohamed MT PLoS One; 2020; 15(8):e0237072. PubMed ID: 32745151 [TBL] [Abstract][Full Text] [Related]
2. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia. Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865 [TBL] [Abstract][Full Text] [Related]
3. Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study. Berendsen MLT; van Maaren MC; Arts EEA; den Broeder AA; Popa CD; Fransen J J Rheumatol; 2017 Sep; 44(9):1325-1330. PubMed ID: 28668802 [TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort. Mouterde G; Rincheval N; Lukas C; Daien C; Saraux A; Dieudé P; Morel J; Combe B Arthritis Res Ther; 2019 Jun; 21(1):140. PubMed ID: 31171038 [TBL] [Abstract][Full Text] [Related]
5. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals. Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231 [TBL] [Abstract][Full Text] [Related]
6. Expansion of Alternative Autoantibodies Does Not Follow the Evolution of Anti-Citrullinated Protein Antibodies in Preclinical Rheumatoid Arthritis: An Analysis in At-Risk First Degree Relatives. Anaparti V; Smolik I; Meng X; O'Neil L; Jantz MA; Fritzler MJ; El-Gabalawy H Arthritis Rheumatol; 2021 May; 73(5):740-749. PubMed ID: 33538122 [TBL] [Abstract][Full Text] [Related]
7. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study. van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045 [TBL] [Abstract][Full Text] [Related]
8. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF. Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323 [TBL] [Abstract][Full Text] [Related]
9. Nodular rheumatoid arthritis (RA): A distinct disease subtype, initiated by cadmium inhalation inducing pulmonary nodule formation and subsequent RA-associated autoantibody generation. Murphy D; Sinha-Royle E; Bellis K; Harrington C; Hutchinson D Med Hypotheses; 2019 Jan; 122():48-55. PubMed ID: 30593421 [TBL] [Abstract][Full Text] [Related]
10. Combination of anti-citrullinated protein antibodies and rheumatoid factor is associated with increased systemic inflammatory mediators and more rapid progression from preclinical to clinical rheumatoid arthritis. Lingampalli N; Sokolove J; Lahey LJ; Edison JD; Gilliland WR; Holers VM; Deane KD; Robinson WH Clin Immunol; 2018 Oct; 195():119-126. PubMed ID: 29842946 [TBL] [Abstract][Full Text] [Related]
11. Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria. Nordberg LB; Lillegraven S; Lie E; Aga AB; Olsen IC; Hammer HB; Uhlig T; Jonsson MK; van der Heijde D; Kvien TK; Haavardsholm EA; Ann Rheum Dis; 2017 Feb; 76(2):341-345. PubMed ID: 27094444 [TBL] [Abstract][Full Text] [Related]
12. Role of Anti-Carbamylated Protein Antibodies Compared to Anti-Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First-Degree Relatives, and Healthy Controls. Koppejan H; Trouw LA; Sokolove J; Lahey LJ; Huizinga TJ; Smolik IA; Robinson DB; El-Gabalawy HS; Toes RE; Hitchon CA Arthritis Rheumatol; 2016 Sep; 68(9):2090-8. PubMed ID: 26946484 [TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Aletaha D; Alasti F; Smolen JS Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354 [TBL] [Abstract][Full Text] [Related]
14. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353 [TBL] [Abstract][Full Text] [Related]
15. The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritis. Barra LJ; Pope JE; Hitchon C; Boire G; Schieir O; Lin D; Thorne CJ; Tin D; Keystone EC; Haraoui B; Jamal S; Bykerk VP; Rheumatology (Oxford); 2017 May; 56(5):768-776. PubMed ID: 28073956 [TBL] [Abstract][Full Text] [Related]
16. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Shi J; van de Stadt LA; Levarht EW; Huizinga TW; Toes RE; Trouw LA; van Schaardenburg D Arthritis Rheum; 2013 Apr; 65(4):911-5. PubMed ID: 23279976 [TBL] [Abstract][Full Text] [Related]
17. Inflammation functions as a key mediator in the link between ACPA and erosion development: an association study in Clinically Suspect Arthralgia. Ten Brinck RM; Toes REM; van der Helm-van Mil AHM Arthritis Res Ther; 2018 May; 20(1):89. PubMed ID: 29720256 [TBL] [Abstract][Full Text] [Related]
18. The family history of rheumatoid arthritis in anti-cyclic citrullinated peptide antibody-positive patient is not a predictor of poor clinical presentation and treatment response with modern classification criteria and treatment strategy: the ANSWER cohort study. Murata K; Hashimoto M; Yamamoto W; Son Y; Amuro H; Nagai K; Takeuchi T; Katayama M; Maeda Y; Ebina K; Hara R; Jinno S; Onishi A; Murakami K; Tanaka M; Ito H; Mimori T; Matsuda S Rheumatol Int; 2020 Feb; 40(2):217-225. PubMed ID: 31620864 [TBL] [Abstract][Full Text] [Related]
19. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Bos WH; Wolbink GJ; Boers M; Tijhuis GJ; de Vries N; van der Horst-Bruinsma IE; Tak PP; van de Stadt RJ; van der Laken CJ; Dijkmans BA; van Schaardenburg D Ann Rheum Dis; 2010 Mar; 69(3):490-4. PubMed ID: 19363023 [TBL] [Abstract][Full Text] [Related]
20. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive. Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]